The experimental models of parkinson's disease in animals

被引:0
|
作者
Grigoryan, G.A. [1 ]
Bazyan, A.S. [1 ]
机构
[1] Institute of Higher Nervous Activity and Neurophysiology, RAN, Moscow
来源
Uspekhi Fiziologicheskikh Nauk | 2007年 / 38卷 / 04期
关键词
Nigrostriatal dopaminergic system - Sporadic form - Toxic protein;
D O I
暂无
中图分类号
学科分类号
摘要
The current review describes the modern Parkinson's disease models in animals, their advantages, limitations and disadvantages. It was noted that the most widespread up-to-date models based on etiology of the Parkinson's disease. Although toxins mostly produce the Parkinson's disease, a study of involved genes allows investigating not only inherited but also sporadic (not inherited) forms of disease since the same genes are involved in both cases. Mutations of genes lead to formation of mutant toxic proteins, which produce a death of the specialized neurons of the nigrostriatal dopaminergic system and the development of Parkinson's disease. A significant place in the review takes a description of characteristics of the toxic models produced by 6-OHDA, MPTP and rotenone, their similarities and differences in pathogenetic mechanisms of the Parkinson's disease development. On the basis of the considered experimental models of Parkinson's disease a conclusion has been done that none of these models may in full and adequate scale imitate the entire clinical, pathophysiological, morphological, biochemical and other aspects of the Parkinson's disease development.
引用
收藏
页码:80 / 88
相关论文
共 50 条
  • [31] Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson's Disease
    Koppula, Sushruta
    Kumar, Hemant
    More, Sandeep Vasant
    Kim, Byung Wook
    Kim, In Su
    Choi, Dong Kug
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (08): : 10608 - 10629
  • [32] Neuroprotective effects of nicotine in two experimental models of Parkinson's disease in the rat
    Murray, TK
    Swettenham, JB
    Hicks, CA
    Winny, C
    O'Neill, MJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 113 - 113
  • [33] Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease
    Bellucci, Arianna
    Navarria, Laura
    Zaltieri, Michela
    Falarti, Elisa
    Bodei, Serena
    Sigala, Sandra
    Battistin, Leontino
    Spillantini, MariaGrazia
    Missale, Cristina
    Spano, PierFranco
    JOURNAL OF NEUROCHEMISTRY, 2011, 116 (04) : 588 - 605
  • [34] Animal models of Parkinson's disease
    Blandini, Fabio
    Armentero, Marie-Therese
    FEBS JOURNAL, 2012, 279 (07) : 1156 - 1166
  • [35] Evaluation of Models of Parkinson's Disease
    Jagmag, Shail A.
    Tripathi, Naveen
    Shukla, Sunil D.
    Maiti, Sankar
    Khurana, Sukant
    FRONTIERS IN NEUROSCIENCE, 2016, 9
  • [36] Animal Models for Parkinson's Disease
    Patil, Dilip A.
    Patil, Vishal A.
    Bari, Sanjay B.
    Surana, Sanjay J.
    Patil, Pravin O.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (09) : 1580 - 1594
  • [37] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    NEURON, 2003, 39 (06) : 889 - 909
  • [38] Cellular models for Parkinson's disease
    Falkenburger, Bjoern H.
    Saridaki, Theodora
    Dinter, Elisabeth
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 121 - 130
  • [39] Models of Parkinson's disease revisited
    Wichmann, Thomas
    NATURE, 2018, 557 (7704) : 169 - 170
  • [40] MODELS OF PARKINSON'S DISEASE IN VITRO
    Azizova, D.
    Sabirova, R.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E92 - E93